Intel Corp. shares rose 6% on Wednesday amid a broad uptick across technology stocks and after positive commentary from an analyst at Lynx Equity. The analyst highlighted progress in addressing client wafer supply challenges that had contributed to the company's below-seasonal first quarter guidance issued three months earlier.
Lynx Equity analyst KC Rajkumar said the earlier guidance had been affected by an undersupply of client wafers, while demand that went unmet is expected to remain into upcoming quarters. Rajkumar described recent industry checks as showing particularly strong activity at the company’s Intel 7 and 14nm nodes.
Rajkumar said, "Our checks show strong activity at Intel 7 and 14nm nodes, perhaps the strongest in recent years. These older nodes are running at full utilization, at higher wafer throughput. And yet the demand may have galloped further ahead, with the supply shortfall as much as 50% of current demand. If the supply situation has improved, going by the CFO’s comments at the Q4 call 'we would expect to be better than seasonal through the year'."
Based on that assessment, the analyst suggested Intel could report first quarter results above the midpoint of its revenue guidance and that the company may be positioned for quarters that outpace typical seasonal patterns. Rajkumar also flagged that these potential upside scenarios might not yet be fully reflected in the stock’s current valuation.
In addition to supply commentary, the analyst questioned Intel’s recent repurchase of a 49% stake in its Ireland fabrication facility, raising the possibility that an external customer could be involved in the transaction.
Reflecting his views on near-term execution and longer-term potential, Lynx Equity raised its price target on Intel to $70 from $65. The firm increased the applied price-to-sales multiple to 6x from 5x in its valuation work.
The market response - a 6% share-price gain on Wednesday - occurred alongside the broader technology sector strength and followed the analyst’s published notes and valuation update. The commentary emphasized both operational indicators at specific process nodes and balance-sheet or capital-allocation questions tied to the Ireland fab stake transaction.
Context and next steps: The analyst’s checks and the company’s CFO remarks were cited as the basis for potentially better-than-seasonal performance; upcoming quarterly results will clarify whether revenue comes in above guidance midpoints and whether wafer supply dynamics materially improve.